Fibroblast growth factor receptor 3 gene (FGFR3) mutations in high-grade muscle-invasive urothelial bladder cancer in a Brazilian population: evaluation and prevalence
Einstein (São Paulo, Online); 20 (), 2022
ABSTRACT Objective To understand the feasibility of FGFR3 tests in the Brazilian public health context, and to sample the mutational burden of this receptor in high-grade muscle invasive bladder cancer. Methods A total of 31 patients with high-grade muscle-invasive bladder cancer were included in the...
Brasil, Carcinoma de Células Transicionales/genética, Carcinoma de Células Transicionales/metabolismo, Carcinoma de Células Transicionales/patología, Eosina Amarillenta-(YS), Hematoxilina, Músculos/metabolismo, Músculos/patología, Mutación, Prevalencia, ARN, Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos/genética, Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos/metabolismo, Neoplasias de la Vejiga Urinaria/genética